Our results were, however, confined to a group with predominantly ischemic origin (30 out of 42) of CHF, and cannot provide reliable evidence on alteration of IL-17 expression and Th17 count in patients with non-ischemic CHF. This evidence concerns the gene IL17A and congestive heart failure.